FDA limits tomato cancer claims
Heinz says ruling will let it promote benefits of products
The Food and Drug Administration has endorsed only a few of the many cancer-fighting claims manufacturers wanted to use in promoting tomato-based products and dietary supplements containing the antioxidant lycopene. (Full article: 564 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
